NIK (human) (326-686)
Anti-NFkB Inducing Kinase NIK antibody (ab228587) | Abcam
Negative Feedback in Noncanonical NF-κB Signaling Modulates NIK Stability Through IKKα-Mediated Phosphorylation | Science Signaling
Possible mechanism of the effect of aging and heptadecane on the... | Download Scientific Diagram
NF-κB-inducing kinase activates IKK-α by phosphorylation of Ser-176 | PNAS
NF-κB Inducing Kinase, NIK Mediates Cigarette Smoke/TNFα-Induced Histone Acetylation and Inflammation through Differential Activation of IKKs | PLOS ONE
NF-κB inducing kinase: A key regulator in the immune system and in cancer - ScienceDirect
Kinase Selectivity Profiling Systems—STE and TKL
Pharmacological inhibition of NF-κB-inducing kinase (NIK) with small molecules for the treatment of human diseases - RSC Medicinal Chemistry (RSC Publishing) DOI:10.1039/D0MD00361A
NF-κB inducing kinase (NIK) inhibitors: Identification of new scaffolds using virtual screening - ScienceDirect
Schematic representation of Nuclear Factor-κB (NF-κB)-inducing kinase... | Download Scientific Diagram
Functional interplay between NF-κB-inducing kinase and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma | Haematologica
Nck-Interacting Ste20 Kinase Couples Eph Receptors to c-Jun N-Terminal Kinase and Integrin Activation | Molecular and Cellular Biology
Discovery of a Potent and Selective NF-κB-Inducing Kinase (NIK) Inhibitor That Has Anti-inflammatory Effects in Vitro and in Vivo | Journal of Medicinal Chemistry
IJMS | Free Full-Text | Targeting NF-κB-Inducing Kinase (NIK) in Immunity, Inflammation, and Cancer
NIK Antibody | Cell Signaling Technology
NIK as a Druggable Mediator of Tissue Injury: Trends in Molecular Medicine
Structure-Based Design of Tricyclic NF-κB Inducing Kinase (NIK) Inhibitors That Have High Selectivity over Phosphoinositide-3-kinase (PI3K) | Journal of Medicinal Chemistry
IJMS | Free Full-Text | Targeting NF-κB-Inducing Kinase (NIK) in Immunity, Inflammation, and Cancer
NFkB Inducing Kinase NIK Polyclonal Antibody (BS-0074R)
NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus | Nature Communications
Cells | Free Full-Text | Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets
Frontiers | The Therapeutic Potential of Targeting NIK in B Cell Malignancies
